USPTO serial 97697661
Serial No. 97697661
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- STOIDES, KATHERINE
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with Serial No. 97697661?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Recursion Pharmaceuticals, Inc.
Salt Lake City, UT, US
Recursion Pharmaceuticals, Inc.
Salt Lake City, UT, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David P. Johnson
David P. Johnson WORKMAN NYDEGGER60 E SOUTH TEMPLESUITE 1000SALT LAKE CITY, UT 84111Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable virtual goods, namely, computer programs featuring computer software for designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds, performing pharmaceutical research and development, performing scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments, for use in contract research services in support of scientific research and development of pharmaceutical preparations, for providing technical consultancy and services in relation to technical research in the field of pharmaceuticals, for use in consultancy in relation to scientific research in the field of pharmaceuticals, for providing medical research and scientific research information in the field of medicine and pharmaceuticals, for use in drug discovery services, for use in drug use discovery services, for use in scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, and conducting and evaluating clinical trials, all for use in the metaverse, online, and in online virtual worlds | ACTIVE | — |
| 035 | Virtual retail store services featuring virtual computer software for use in designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds, performing pharmaceutical research and development services, performing scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments, for use in contract research services in support of scientific research and development of pharmaceutical preparations, for providing technical consultancy and services in relation to technical research in the field of pharmaceuticals, for use in consultancy in relation to scientific research in the field of pharmaceuticals, for providing medical research and scientific research information in the field of medicine and pharmaceuticals, for use in drug discovery services, for use in drug use discovery services, for use in scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, and conducting and evaluating clinical trials; On-line retail store services featuring computer software for use in designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyzing data, developing pharmaceutical products and chemical compounds, performing pharmaceutical research and development, performing scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments, for use in contract research services in support of scientific research and development of pharmaceutical preparations, for providing technical consultancy and services in relation to technical research in the field of pharmaceuticals, for use in consultancy in relation to scientific research in the field of pharmaceuticals, for providing medical research and scientific research information in the field of medicine and pharmaceuticals, for use in drug discovery services, for use in drug use discovery services, for use in scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, and conducting and evaluating clinical trials | ACTIVE | — |
| 042 | Providing temporary use of online, non-downloadable computer software for use in designing clinical trials and forecasting clinical trial results, searching for clinical trial patients, analyzing medical images, analyze data, and developing pharmaceutical products and chemical compounds, performing pharmaceutical research and development, performing scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments, for use in contract research services in support of scientific research and development of pharmaceutical preparations, for providing technical consultancy and services in relation to technical research in the field of pharmaceuticals, for providing consultancy in relation to scientific research in the field of pharmaceuticals, for providing medical research and scientific research information in the field of medicine and pharmaceuticals, for use in drug discovery services, for use in drug use discovery services, for use in scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, and conducting and evaluating clinical trials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 3, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 3, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 3, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 3, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 10, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 27, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 26, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 26, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 12, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 14, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 15, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 16, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 9, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 9, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 9, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 9, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 12, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 23, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 22, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 3, 2022 | NWAP | NEW APPLICATION ENTERED | — |